The direct effects of clofibrate analogues on carnitine acyltransferase activities and fatty acid metabolism were studied in cultured hepatocytes. Rat hepatocytes cultured with bezafibrate or ciprofibrate (0.1-10 pg/ ml) for 48 h had increased activities of carnitine acetyltransferase '(CAT; 4-6-fold) and carnitine palmitoyltransferase (CPT; 12-34%). The increase in CAT was higher in hepatocytes from the periportal zone (440 %) of rat liver compared with cells from the perivenous zone (266 %). In human hepatocytes, in contrast with rat, the fibrates did not cause a marked increase in CAT activity. The effects of fibrates on palmitate metabolism were dependent on the carnitine status. In the presence of exogenous carnitine (1 mM), rat hepatocytes cultured with bezafibrate had higher rates of total palmitate metabolism (29-34 %) without increased partitioning of-palmitate towards fl-oxidation, relative to control cultures. At low endogenous carnitine concentrations, cells cultured with bezafibrate had a greater increase in palmitate metabolism, esterification and cellular accumulation of triacylglycerol compared with the corresponding increases in the presence of carnitine. The changes in palmitate metabolism at either high or low carnitine concentrations were small in comparison with the changes in CAT activity. It is concluded that the increase in hepatic carnitine that occurs in vivo after fibrate feeding probably plays the major role in the changes in partitioning of fatty acid between fl-oxidation and esterification.
INTRODUCTION
Clofibrate analogues (fibrates) are used clinically to lower the plasma [triacylglycerol] in patients with hyperlipidaemia. The mechanism of action of these compounds seems to involve both increased clearance of very-low-density lipoproteins and decreased production by the liver [1, 2] . The effects of fibrates on the liver have been studied mainly in rodents. In the rat, fibrates cause: marked proliferation of peroxisomes [3] , increased peroxisomal [4] and mitochondrial [5] fl-oxidation capacity, increased activities of carnitine acetyltransferase (CAT) and acyl-CoA hydrolases [6] [7] [8] , and increased hepatic carnitine [9, 10] and CoA [11, 12] . Several mechanisms have been proposed by which fibrates decrease hepatic production of triacylglycerol, including: (i) decreased fatty acid availability [1] ; (ii) increased intrahepatic diversion of fatty acids towards peroxisomal and mitochondrial fl-oxidation, as opposed to esterification to glycerolipid [13] ; (iii) inhibition of glycerolipid formation [14] ; and (iv) inhibition of very-low-densitylipoprotein secretion [15] . Studies on perfused liver or hepatocytes from rats treated with fibrates in vivo have shown increased rates of fatty acid f-oxidation [5, 10, [16] [17] [18] [19] , associated with either decreased [16, 19] or unchanged or increased [5, 10] rates of fatty acid esterification. Clofibrate has been shown to lower plasma insulin in the rat [20] . Since hepatic fatty acid metabolism is critically dependent on plasma insulin and glucagon concentrations, it is not clear to what extent the observed changes in fatty acid metabolism in hepatocytes isolated from rats treated with fibrates in vivo are due to direct effects of fibrates on the liver or to secondary endocrine changes.
The aims of the present study were: first, to investigate whether fibrates have a direct effect on the partitioning of fatty acids between fl-oxidation and esterification in cultured hepatocytes, and to examine whether insulin and glucagon influence the effects of fibrates on lipid metabolism; second, to examine whether changes in fatty acid metabolism correlate with changes in CAT activity; third, to compare some of the effects of these drugs in rat and human hepatocytes.
MATERIALS AND METHODS Materials
Bezafibrate {2- [4-(chlorobenzamidoethyl) the hepatocytes were preincubated in Minimum Essential Medium (Eagle) for 20 min at 37 'C. They were then sedimented (50 g, 2 min) and washed twice in the same medium and once in medium with 1 % (w/v) bovine serum albumin. Cell viability was > 90 %.
Rat periportal and perivenous hepatocytes were isolated from male Wistar rats (150-200 g body wt.) obtained from Bantin and Kingman (Hull, U.K.) by digitonin/collagenase perfusion by the method of Quistorff [23] with the following modifications: (i) perfusion media were buffered with Hepes instead of bicarbonate (1O mm, pH 7.5, for the first two media; 20 mm and 50 mM, pH 7.6, for the collagenase medium and digitonin soln. respectively); (ii) separate peristaltic pumps were used for each medium, and the digitonin soln. (4 mg/ml) was injected with a 10 ml syringe, approx. 5 ml in 1 min for isolation of periportal cells and 3 ml in 3 s for isolation of perivenous cells. After liver perfusion, which lasted about 40-50 min, the hepatocytes were sedimented and washed as above, except that the preincubation was omitted. Cell yield was (1-2) x 108 for periportal cells and (0.5-1) x 108 for perivenous cells, and viability was > 90%.
Human hepatocytes were isolated from liver sections (100-150 g) from kidney donors (male; 48, 19 and 29 years old) by a two-step perfusion. This involved perfusion without recirculation with 1.5 litres of buffer containing 150 mM-NaCl, 6.7 mM-KCl, 10 mM-Hepes and 0.1 mM-EDTA, pH 7.5, followed by perfusion with 500 ml of buffer containing 120 mM-NaCl, 6 .7 mM-KCl, 30 mM-Hepes, 5 mM-CaC12 and collagenase (Type IV; 90 mg/500 ml), pH 7.6, which was recirculated for 45 min. After dissociation of the liver, the hepatocytes were allowed to sediment at 1 g for 20 min at room temperature and then washed as described for rat hepatocytes. Cell viability was 60-70 %.
Hepatocyte culture
The hepatocytes were suspended in Minimum Essential Medium with 5 % (v/v) fetal-bovine serum (4 x 105 cells/ ml) and plated (4 ml per flask) in 25 cm2 culture flasks. The time allowed for attachment was 4-7 h for rat hepatocytes and 12 h for human hepatocytes. The medium was then replaced by serum-free Minimum [24] . Palmitate was determined in the untreated medium enzymically [25] . The hepatocyte monolayer was rinsed twice with 150 mM-NaCl, and the cells were extracted in buffer containing 100 mM-KC1, 50 mM-Tris, 20 mM-KF, 5 mM-EDTA and 0.05 % (w/v) Lubrol PX, pH 7.9. Triacylglycerol was determined in the cell extract [26] . The rate of fatty acid metabolism was determined from the difference in [palmitate] in the medium at the beginning and end of the 4 h incubation. f-Oxidation of palmitate was determined from the conversion of[U-_4C]-palmitate into 14C-labelled-acid-soluble metabolites, and ketogenesis was determined from the accumulation of acetoacetate and 3-hydroxybutyrate. Rates were linear during 4 h.
Enzyme activities
Enzymes were assayed at 30 'C in a centrifugal analyser (Cobas Bio 8326; Hofmann-La Roche). CAT and CPT were assayed by monitoring the formation of CoA by using the thiol reagent 5,5'-dithiobis-(2-nitrobenzoate) (DTNB) by modifications of established methods [27, 28] . 
RESULTS

Effects of bezafibrate on enzyme activities in rat hepatocyte cultures
In rat hepatocytes cultured for 48 h with either insulin (10 nM) or glucagon (100 nM), bezafibrate caused 6-and 4-fold increases in CAT activity respectively. The activities of CPT, acetyl-CoA hydrolase and palmitoylCoA hydrolase were increased by 20-50 % (Table 1) . Total cell protein was also increased (12-18 %, P < 0.01) (Table 1) . In experiments where the effects of bezafibrate (0.1-1O /tsg/ml) were examined after either 2 or 4 days, the highest bezafibrate concentration caused a 9-fold increase in CAT activity after 4 days (cf. 6-fold at 2 days) compared with controls. Total cell protein and CAT activity declined between 2 and 4 days by about 40 % in the control cultures, and, although the difference in CAT activity between the bezafibrate-treated cultures and the controls was greater in percentage terms after 4 days, the difference was similar in absolute terms at 2 and 4 days. In the rest of this study experiments were terminated after 2 days.
Studies on the effects of cell inoculation density showed that the effects of bezafibrate (0.1-10 jg/ml) on the activities of CAT, CPT and acetyl-and palmitoylCoA hydrolases after 48 h were similar in cultures inoculated at densities of 0.63 x 106, 1.25 x 10w and 2.5 x 106 cells per flask (n = 3 cultures; results not shown). Table 2 shows the effects of bezafibrate on CAT activity in rat hepatocytes isolated from either the periportal or the perivenous zone of rat liver. In agreement with previous studies [23, 31] , periportal cells had higher alanine aminotransferase activity, lower glutamate dehydrogenase activity ( Table 2 ). Effects of fibrates in rat and human hepatocytes
In rat hepatocyte cultures, bezafibrate and ciprofibrate had similar -effects on CAT activity at the highest concentration (10 l,g/ml), but ciprofibrate was more potent at lower concentrations (Table 3) . In human hepatocytes, CAT activity was 8-fold higher than in rat hepatocytes (Table 3) , and acetyl-CoA hydrolase activity was not detectable. This contrasts with the lower transferase relative to hydrolase activity in rat liver cells (Table 1) . In human hepatocytes, in contrast with rat cells, the fibrates did not cause a marked increase in CAT activity. The small increase (Table 3) was not statistically significant, but the trends were similar in the three experiments. Effects of bezafibrate on fatty acid metabolism in rat hepatocytes Table 4 shows the effects of bezafibrate on the rates of palmitate metabolism (expressed per flask) and also the rates expressed per mg of protein. The total cell protein was higher (P < 0.005) in the insulin-treated than in glucagon-treated cultures (Table 4) , presumably because of a higher rate of proteolysis in the latter cultures. The glucagon-treated cultures had higher rates of palmitate metabolism compared with the insulin-treated cultures when rates were expressed on a protein basis (Table 4 ).
In the presence ofcarnitine (1 mM) the rate of palmitate metabolism, determined from the decrease in [palmitate] in the medium, was twice the rate of conversion of palmitate into acid-soluble metabolites. Since the conversion of [U-14Cqpalmitate into "4CO2 represents less than 5 % of the conversion into acid-soluble metabolites, the latter approximates to the rate of fl-oxidation [21] .
The rate of esterification was estimated from the difference between rates of palmitate metabolism and fl-oxidation. There was little secretion of triacylglycerol into the medium during 4 h (< 15 nmol of triacylglycerol/flask), compared with the rate of palmitate uptake (400-500 nmol of palmitate/flask; Table 4 ). The triacylglycerol content of the cells before the 4 h incubation with palmitate was about 20-50 % of the triacylglycerol content after 4 h incubation with palmitate, suggesting that 50-80 % of the cellular triacylglycerol at the end of the experiment (Table 4) was formed during incubation with palmitate.
The bezafibrate-cultured cells had higher rates (P < in the insulin-treated cultures and 16-23 % in the glucagon-treated cultures), which probably represents, in part, the induction of specific proteins and proliferation of organelles, and may be analogous to liver hypertrophy induced by fibrates in 'vivo. The effects of bezafibrate on palmitate metabolism were similar in insulin-and glucagon-treated cultures and were small (< 50 %) compared with the changes in CAT activity (400-600 %; Table 1 ). Ciprofibrate had similar effects to bezafibrate on fatty acid metabolism at concentrations of 0.1, 1 and 10,ug/ml (results not shown).
In incubations without exogenous carnitine, rates of conversion of [U-'4C]palmitate into acid-soluble metabolites (which presumably represents fl-oxidation in mitochondria and peroxisomes) anid rates of ketogenesis were lower (61 % and 68 % respectively; P < 0.0001) than in the presence of 1 mM-carnitine ( Table 4 ), indicating that endogenous carnitine limits fatty acid oxidation in cultured hepatocytes [21] . Rates of fatty acid esterification were higher (P < 0.01) in incubations without carnitine (Table 4) , probably because of decreased diversion of fatty acids towards oxidation. The lower rate of fl-oxidation was associated with a lower rate of palmitate uptake (22 %, P < 0.05), indicating that carnitine deficiency influenced not only the partitioning of palmitate between different pathways but also total palmitate metabolism. In incubations without carnitine, with increasing [bezafibrate] the formation of ketone bodies decreased (28 %), whereas the formation ofacid-soluble metabolites increased (23 %, P < 0.05; Table 4 ); consequently, ketone bodies accounted for a lower proportion of total fl-oxidation in bezafibrate-treated cultures (29 % at 10 jug/ml) than in controls (47 %). Bezafibrate caused a greater increase in palmitate esterification (P < 0.01), which was paralleled by higher cellular triacylglycerol (P < 0.01), in the carnitine-free cultures than with 1 mMcarnitine (Table 4) .
DISCUSSION
Clofibrate analogues induce proliferation of peroxisomes in rat liver, but not in human liver [32] [33] [34] [35] . It is not known which of the changes observed in rat liver are Although studies on rats given fibrates have suggested increased hepatic partitioning of fatty acids towards fl-oxidation, as opposed to esterification [16, 19] , this may be due to secondary endocrine or metabolic changes rather than a direct effect of fibrates on enzymes involved in fatty acid metabolism. There is good evidence that hepatocyte cultures are a good model in which to study changes in enzyme activities induced by fibrates [36] [37] [38] . Since hepatocyte cultures lose their endogenous carnitine when maintained in the absence of carnitine precursors [21] , they can be used to study changes in lipid metabolism induced by fibrates that are independent of carnitine changes. In the present study, the effects of fibrates on fatty acid metabolism in cultured hepatocytes were examined in the absence or presence of exogenous carnitine to establish conditions in which carnitine is either limiting or in excess.
The following conclusions are drawn from this study.
(1) In the presence of exogenous carnitine, bezafibrate caused small increases in rates of palmitate metabolism (29 and 34 % in insulin-and glucagon-treated cultures respectively) and esterification (35 and 51 %), but it did not increase the proportion of palmitate metabolized by fl-oxidation. It is therefore inferred that bezafibrate does not inhibit esterification, and for a constant [carnitine] it does not increase the partitioning of palmitate towards ,-oxidation.
(2) The effects of bezafibrate on palmitate metabolism were dependent on the carnitine status, such that, at low carnitine concentrations, bezafibrate caused greater increases in palmitate esterification and accumulation of triacylglycerol than at high carnitine concentrations, and it decreased rather than increased ketogenesis. The finding that bezafibrate can have opposite effects on ketogenesis in the absence or presence of exogenous carnitine may explain why, in a recent study, bezafibrate decreased palmitate fl-oxidation [39] . The results suggest that bezafibrate increases the capacity for f8-oxidation and esterification, but the partitioning between both pathways depends on the carnitine status.
(3) The changes in palmitate metabolism caused by bezafibrate were much smaller than the changes in CAT activity, suggesting that the induction of this enzyme may not be important in the changes in lipid metabolism.
(4) The finding that bezafibrate caused a several-fold increase in CAT activity and a smaller increase in hydrolase activity in cultured rat hepatocytes agrees with the changes in vivo [12] , and is further evidence that fibrates induce similar changes in enzyme activities in rat hepatocyte cultures to those in rat liver in vivo.
(5) The increase in CAT activity was more prominent in rat hepatocytes derived from the periportal zone than from the perivenous zone, suggesting that there may be a heterogeneous response to at least some of the effects of fibrates in different zones of the liver acinus. Fibrates may induce their multiple effects in hepatocytes either by direct interaction with specific recognition sites or receptors [40] or by conversion into CoA esters or other conjugates [41] . The more marked effect of fibrates in periportal cells may be due either to differences in 'recognition sites' in different cells or to more general mechanisms related to conjugation or degradation.
(6) Bezafibrate and ciprofibrate had different effects on CAT activity in rat and human hepatocytes. Since human hepatocytes have a much higher CAT activity than do rat hepatocytes, the failure to observe a severalfold increase in activity in human hepatocytes is not surprising. Morphometric studies have shown that fibrates have different effects on proliferation of organelles in human and rat liver [32] [33] [34] [35] . The present findings suggest that cultures of rat and human hepatocytes in vitro can be used to identify and characterize biochemical differences between rat and human liver.
It is well established that fibrates increase hepatic carnitine in the rat in vivo [9, 10] . Since bezafibrate did not increase the proportion ofpalmitate that was metabolized by fl-oxidation in cultures incubated with 1 mM-carnitine, and it also did not inhibit esterification, the increased partitioning of palmitate towards f-oxidation in hepatocytes or perfused liver isolated from rats treated with fibrates [16, 19] is unlikely to be due to either peroxisomal proliferation or inhibition of esterification, but more likely to be due to the increase in hepatic carnitine.
Studies on the relation between the rate of fl-oxidation and the hepatocyte carnitine content have suggested that, whereas in cells from fasted rats a maximum rate of fl-oxidation occurs at a [carnitine] within the physiological range, in cells from re-fed rats a higher than physiological concentration of endogenous carnitine is required for maximum fl-oxidation [42] . This suggests that endogenous carnitine may limit f-oxidation in the fed state. This supports the hypothesis that the increase in hepatic carnitine in rats treated with fibrates may be the major factor responsible for increased partitioning of fatty acids towards fl-oxidation.
